降低乙肝疫苗出生剂量对未来免疫接种量的影响
1Office of Immunization at the Rhode Island Department of Health, Providence, RI.
Rhode Island medical journal (2013)
|February 25, 2026
概括
罗德岛州的乙型肝炎 (HepB) 出生剂量疫苗接种覆盖率正在下降,这影响了幼儿园免疫率. 这一趋势凸显了改善儿童接种疫苗的必要性.
科学领域:
- 公共卫生 公共卫生
- 免疫科学 免疫科学
- 儿科医学 儿科医学
背景情况:
- 儿童疫苗接种是一个关键的公共卫生战略,但疫苗覆盖率下降和疫苗犹带来了重大风险.
- 乙型肝炎 (HepB) 出生剂量疫苗接种是父母遵守免疫计划的关键指标.
- 罗德岛州最近的趋势显示,HepB出生剂量覆盖率有所下降.
研究的目的:
- 为了检查罗德岛州HepB出生剂量覆盖率的最新趋势.
- 分析HepB出生剂量管理和随后的疫苗完成之间的关系.
- 评估对幼儿园免疫接种合规性的影响.
主要方法:
- 利用罗德岛儿童和成人免疫注册表 (RICAIR) 的免疫记录,用于2019年至2025年中期出生的婴儿.
- 分类 HepB 疫苗接种时间:出生剂量,早期井检查,或在 3 个月内没有剂量.
- 根据HepB疫苗接种时间,比较24个月前完成7系列疫苗接种和幼儿园免疫合规性.
主要成果:
- 到2025年第二季度,HepB出生剂量覆盖率降至84.2%,至2025年第二季度.
- 接种HepB分娩剂量的婴儿在幼儿园免疫率 (91.1%) 比较高,与晚期接种疫苗 (81.8%) 或没有早期剂量 (10.1%) 相比.
- 如果目前的趋势继续下去,预计幼儿园合规率可能从88.8%降至85.3%.
结论:
- 在HepB出生剂量管理的下降信号减弱疫苗的信心和坚持.
- 需要在公共卫生,产前和儿科部门采取紧急,协调的干预措施.
- 扭转这一趋势对于保持高的幼儿免疫率至关重要.
相关概念视频
01:51Vaccinations
52.3K
Overview
52.3K
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
314
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
314
01:21Factors Affecting Drug Response: Overview
3.2K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.2K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
334
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
334
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
381
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
381
01:22Development of Immunocompetence
1.0K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.0K